Signal copy number (SCN) and signal intensity (SI) of subtelomeres (ST) are investigated in auxiliary lymph node (ALN) and buccal (BUC) cells by fluorescence in situ hybridization. The extracted total cell of 38256 and 2309 was, respectively, analyzed from the benign ALN- and BUC-cells of an affected breast cancer patient. The Periodic model was based on ST behavior including normal-, down-, and upregulated clones with diverse SCN. The arm-p/q ratio based signature, as a subtelomeric array, reflects discordance and concordance of ST-behavior within individual chromosomes as a concept of “Individualization of Cells” rather than “Global Insight of Cells”. The Periodic charts could be considered as a reliable and refreshable platform through which the cellular evolution could be patterned and characterized. Signature of ST-profile in the BUC and ALN cells and the nature of diverse SCN and SI as quantitative and qualitative value led to modeling the real personalized perspective of cellular evolution. Protein expression of Ki67, Cyclin D1, and Cyclin E was assayed, as a complementary panel. These targets could be applied as the predictive and preventive markers for an early detection at BUC and ALN levels to plan the required managements in the breast cancer patients. Modeling such signature and mining the subtelomeric signal profiling of individual chromosomes' arms could be translated to a personalized developmental insight in buccal-cells and auxiliary lymph node of breast neoplasm’s cells by Novel Periodic Charts. 1. Introduction The reliability of buccal (BUC) cells is due to its sensitivity to different substances used by people who may be affected with cancer or other diseases. In such process, the materials in the BUC are combined with dietary factors, and/or any environmental hazard elements (http://aghealth.nih.gov/ 2002). The mucous-secreting epithelial, known as mucosa, is classified into two types: (1) masticatory (keratinized) and (2) inside layer (nonkeratinized). The masticatory mucosa appears to be thick, with a denser and less vascular connective tissue component. Keratin acts as a shielding domain against different types of stimuli [1]. BUC cells are, morphologically, characterized with their relatively large size, flat shape, nongranular cytoplasm, centerline located nucleus, and large ratio of cytoplasm to nucleus. Such characteristics make BUC a reliable tissue for investigations in cell biology and genetics. Unmasking the nature of diverse copy number as quantitative value and mode of intensity as qualitative insight could help to
References
[1]
G. Taybos, “Oral changes associated with tobacco use,” The American Journal of the Medical Sciences, vol. 326, no. 4, pp. 179–182, 2003.
[2]
T. de Lange, L. Shiue, R. M. Myers et al., “Structure and variability of human chromosome ends,” Molecular and Cellular Biology, vol. 10, no. 2, pp. 518–527, 1990.
[3]
S. Steinert, J. W. Shay, and W. E. Wright, “Modification of subtelomeric DNA,” Molecular and Cellular Biology, vol. 24, no. 10, pp. 4571–4580, 2004.
[4]
International Human Genome Sequencing Consortium, “Finishing the euchromatic sequence of the human genome,” Nature, vol. 431, pp. 931–945, 2004.
[5]
H. Riethman, A. Ambrosini, C. Castaneda et al., “Mapping and initial analysis of human subtelomeric sequence assemblies,” Genome Research, vol. 14, pp. 18–28, 2004.
[6]
H. der Sarkissian, S. Bacchetti, L. Cazes, and J. A. Londo？o-Vallejo, “The shortest telomeres drive karyotype evolution in transformed cells,” Oncogene, vol. 23, no. 6, pp. 1221–1228, 2004.
[7]
H. C. Mefford and B. J. Trask, “The complex structure and dynamic evolution of human subtelomeres,” Nature Reviews Genetics, vol. 3, no. 2, pp. 91–102, 2002.
[8]
E. V. Linardopoulou, E. M. Williams, Y. Fan, C. Friedman, J. M. Young, and B. J. Trask, “Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication,” Nature, vol. 437, no. 7055, pp. 94–100, 2005.
[9]
M. K. Rudd, C. Friedman, S. S. Parghi, E. V. Linardopoulou, L. Hsu, and B. J. Trask, “Elevated rates of sister chromatid exchange at chromosome ends,” PLoS Genetics, vol. 3, no. 2, article e32, 2007.
[10]
S. M. Gadalla, R. Cawthon, N. Giri, B. P. Alter, and S. A. Savage, “Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes,” Aging, vol. 2, pp. 867–874, 2010.
[11]
L. T. M. Dórea, J. R. C. Meireles, J. P. R. Lessa, et al., “Chromosomal damage and apoptosis in exfoliated buccal cells from individuals with oral cancer,” International Journal of Dentistry, vol. 2012, Article ID 457054, 6 pages, 2012.
[12]
D. J. Wolff, K. Clifton, C. Karr, and J. Charles, “Pilot assessment of the subtelomeric regions of children with autism: detection of a 2q deletion,” Genetics in Medicine, vol. 4, no. 1, pp. 10–14, 2002.
[13]
P. Thomas, N. J. O'Callaghan, and M. Fenech, “Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease,” Mechanisms of Ageing and Development, vol. 129, no. 4, pp. 183–190, 2008.
[14]
J. Lee, X. Lu, E. S. Shin, W. F. Kern, J. J. Mulvihill, and S. Li, “A novel subtelomeric translocation t(5;9) and a deletion of the RB1 gene in a patient with acute myeloid leukemia (AML-M0),” Cancer Genetics and Cytogenetics, vol. 181, no. 1, pp. 36–39, 2008.
[15]
S. Tosi, S. W. Scherer, G. Giudici, B. Czepulkowski, A. Biondi, and L. Kearney, “Delineation of multiple deleted regions in 7q in myeloid disorders,” Genes, Chromosomes & Cancer, vol. 25, pp. 384–392, 1999.
[16]
P. Mehdipour, M. Kheirollahi, M. Mehrazin, N. Kamalian, and M. Atri, “Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic-tumour heterogeneity and instability,” Cell Biology International, vol. 35, no. 9, pp. 915–925, 2011.
[17]
P. Mehdipour, Telomere Territory and Cancer, Springer, Amsterdam, The Netherlands, 2013.
